The world now stands at the frontier of an exciting new industrial landscape, a revolution that that will transform the foundations of manufacturing and medicine. Rapid advances advanced manufacturing technology can provide unparalleled fabrication capabilities that fundamentally challenge the established industry paradigms.
Particularly promising is additive manufacturing for biomedical applications, or additive biomanufacturing (ABM), where personalized and customized approaches can be developed through ABM to help surgeons and clinicians to treat patients with challenging problems ranging from large bone defects to deafness.
The ARC Industrial Transformation Training Centre in Additive Biomanufacturing works collaboratively to develop advanced bioprinters, bioinks, and 3D printed clinical tools to train future leaders and transform the national advanced manufacturing industry by building an emerging additive biomanufacturing sector in Australia.
The Centre is structured into three synergistic and innovative programs:
The RMIT team is focused on innovative approaches for clinical uses of additive manufacturing, building on the experience of St. Vincents, Anatomics and Stryker to advanced medical applications of 3D printing.
This program will investigate and develop AM technology for lattice-based implants and materials for mimicking the radiation properties of lung in collaboration with StVincents and Peter Mac hospitals. This work will enable both a new design of implants and a unique novel line of test objects for radiotherapy to address urgent needs in modern radiotherapy where image guidance, dynamic deliveries and high precision are paramount.